Provided by Tiger Trade Technology Pte. Ltd.

Pharvaris N.V.

31.19
+0.18000.58%
Post-market: 31.190.00000.00%19:50 EDT
Volume:591.39K
Turnover:18.44M
Market Cap:2.18B
PE:-10.42
High:31.55
Open:31.21
Low:30.69
Close:31.01
52wk High:43.25
52wk Low:20.65
Shares:69.86M
Float Shares:44.23M
Volume Ratio:0.89
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9943
EPS(LYR):-3.4871
ROE:-70.46%
ROA:-42.32%
PB:6.43
PE(LYR):-8.94

Loading ...

Pharvaris Announces Positive Topline Data from Chapter-3 Pivotal Study of Deucrictibant Xr for Prophylaxis of Hae Attacks

THOMSON REUTERS
·
Sep 08

Pharvaris N.v. - Topline Data from Creaate Phase 3 Study Expected First Quarter 2027

THOMSON REUTERS
·
Sep 08

Pharvaris N.v. - Chapter-3 Study Met Primary Endpoint with 83% Attack Rate Reduction Versus Placebo

THOMSON REUTERS
·
Sep 08

Pharvaris N.v. - 87% Attack Rate Reduction Versus Placebo in Hae Type 1 or Type 2 Patients

THOMSON REUTERS
·
Sep 08

Pharvaris N.v. - Deucrictibant Xr Demonstrated Well-Tolerated Safety Profile in Chapter-3 Study

THOMSON REUTERS
·
Sep 08

Pharvaris Reports Phase 2 Chapter-1 Extension Data Showing Long-Term Safety, Attack-Rate Drop for Deucrictibant in HAE

Reuters
·
Sep 03

Pharvaris (PHVS) Gets a Buy from Morgan Stanley

TIPRANKS
·
Aug 31

Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Caribou Biosciences (CRBU) and Aveanna Healthcare Holdings (AVAH)

TIPRANKS
·
Aug 14

Pharvaris Could See Significant Upside on Positive Phase 3 Data, RBC Says

MT Newswires Live
·
Aug 14

Pharvaris N.v. : Bofa Global Research Raises Price Objective to $38 from $35

THOMSON REUTERS
·
Aug 13

ProQR Q2 Revenue More than Doubles

Reuters
·
Aug 13

RBC Adjusts PT on Pharvaris to $52 From $51, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 13

Pharvaris N.V. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Pharvaris' Q2 Loss Per Share Narrows

MT Newswires Live
·
Aug 12

Switzerland's Pharvaris Q2 Loss Narrows, Cash Rises to €318 Mln

Reuters
·
Aug 12

Earnings Flash (PHVS) Pharvaris Posts Q2 Loss 0.70 Euro a Share

MT Newswires Live
·
Aug 12

Pharvaris Q2 2026 Loss Widens as Company Cites Higher Clinical and Commercial Buildout Costs

Reuters
·
Aug 12

Pharvaris Q2 EPS $(0.81) Misses $(0.74) Estimate

Benzinga Earnings
·
Aug 12

Pharvaris N.v. Q2 EPS EUR -0.7

THOMSON REUTERS
·
Aug 12

Pharvaris Q2 FY26 Loss Narrows to €47.8 Million; R&D Expenses Rise to €35 Million

Reuters
·
Aug 12